3rd Circ. Allows RICO Class Suit Against GSK Over Avandia
The Third Circuit on Monday allowed union health and welfare funds to pursue a racketeering class action against GlaxoSmithKline LLC over heart risks from the diabetes drug Avandia, finding that allegations...To view the full article, register now.
Already a subscriber? Click here to view full article